Custom-fitted oral appliances reduce airway obstruction by physically repositioning the lower jaw or tongue forward during ...
In a phase 2b clinical trial, an investigational oral therapy called PrimeC was found to be safe and well tolerated in people ...
Laurel Smiles Dental Care has expanded its restorative and orthodontic treatment services in Laurel, Maryland, increasing ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Dosing has begun in a new regimen of the HEALEY ALS platform trial, its ninth, which is testing the oral therapy NUZ-001 for ...
Vivos CARE Oral Medical Devices Proven to Enhance Airways by Redeveloping Dental Arch Forms and Jaws. LITTLETON, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc.
A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining ...
New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...
TIX100 is a specific, orally available TXNIP inhibitor originally developed for its beta-cell protective effects in diabetes. It has received FDA Investigational New Drug approval in diabetes and ...
The phase 3 SUCCESSOR-2 trial shows mezigdomide-based therapy improves PFS in R/R multiple myeloma patients previously exposed to lenalidomide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results